| Structure |
Chemical Name |
CAS |
MF |
![3-Quinolinecarboxylic acid, 8-cyano-1-cyclopropyl-6-fluoro-7-[(4aS,7aS)-hexahydropyrrolo[3,4-b]-1,4-oxazin-6(2H)-yl]-1,4-dihydro-4-oxo-](/CAS/GIF/209342-40-5.gif) |
3-Quinolinecarboxylic acid, 8-cyano-1-cyclopropyl-6-fluoro-7-[(4aS,7aS)-hexahydropyrrolo[3,4-b]-1,4-oxazin-6(2H)-yl]-1,4-dihydro-4-oxo- |
209342-40-5 |
C20H19FN4O4 |
![(2E)-3-(4'-Hydroxy-3'-tricyclo[3.3.1.13,7]dec-1-yl[1,1'-biphenyl]-4-yl)-2-propenoic acid](/CAS/20180906/GIF/496868-77-0.gif) |
(2E)-3-(4'-Hydroxy-3'-tricyclo[3.3.1.13,7]dec-1-yl[1,1'-biphenyl]-4-yl)-2-propenoic acid |
496868-77-0 |
C25H26O3 |
 |
6-Chloro-2-methyl-4-phenyl-alpha-propyl-3-quinolineacetic acid |
957890-42-5 |
C21H20ClNO2 |
![[2-[4-(2-Methoxyphenyl)piperazin-1-yl]ethyl](propyl)(4,5,6,7-tetrahydrobenzothiazol-6-yl)amine](/CAS/GIF/1148156-63-1.gif) |
[2-[4-(2-Methoxyphenyl)piperazin-1-yl]ethyl](propyl)(4,5,6,7-tetrahydrobenzothiazol-6-yl)amine |
1148156-63-1 |
C23H34N4OS |
 |
4-(3-(2H-1,2,3-Triazo-2-yl)phenylaMino)-2-((1R,2S)-2-aMinocyclohexylaMino) pyriMidine-5-carboxaMide |
1370261-96-3 |
C19H23N9O |
![BenzaMide, N-[3-[1,4-dihydro-1-Methyl-7-[(6-Methyl-3-pyridinyl)aMino]-2-oxopyriMido[4,5-d]pyriMidin-3(2H)-yl]-4-Methylphenyl]-3-(trifluoroMethyl)-](/CAS/GIF/839706-07-9.gif) |
BenzaMide, N-[3-[1,4-dihydro-1-Methyl-7-[(6-Methyl-3-pyridinyl)aMino]-2-oxopyriMido[4,5-d]pyriMidin-3(2H)-yl]-4-Methylphenyl]-3-(trifluoroMethyl)- |
839706-07-9 |
C28H24F3N7O2 |
 |
BS194 |
1092443-55-4 |
C20H27N5O3 |
![Quinoxaline, 6-[3-(6-Methyl-2-pyridinyl)-1H-pyrazol-4-yl]-](/CAS/GIF/746667-48-1.gif) |
Quinoxaline, 6-[3-(6-Methyl-2-pyridinyl)-1H-pyrazol-4-yl]- |
746667-48-1 |
C17H13N5 |
 |
CarbaMiMidothioic acid, 3-cyanopropyl ester, hydrochloride (1:1) |
66592-89-0 |
C5H10ClN3S |
 |
ABC294640 |
915385-81-8 |
C23H25ClN2O |
 |
Omadacycline |
389139-89-3 |
C29H40N4O7 |
 |
AS601245 |
345987-15-7 |
C20H16N6S |
 |
AZ-505 |
1035227-44-1 |
C31H39Cl2F3N4O6 |
 |
AZD7545 |
252017-04-2 |
C19H18ClF3N2O5S |
 |
BIX-02565 |
1311367-27-7 |
C26H30N6O2 |
 |
BMS-538203 |
543730-41-2 |
C12H12FNO5 |
 |
CC0651 |
1319207-44-7 |
C20H21Cl2NO6 |
 |
CS 7017 |
223132-38-5 |
C27H28Cl2N4O4S |
 |
Ketone Ester |
1208313-97-6 |
C8H16O4 |
 |
NVP-QAV-572 |
957209-68-6 |
C17H19F2N7O3S2 |
 |
Nirogacestat |
1290543-63-3 |
C27H41F2N5O |
 |
ST 2825 |
894787-30-5 |
C27H28Cl2N4O5S |
 |
TG 100572 (Hydrochloride) |
867331-64-4 |
C26H27Cl2N5O2 |
 |
Saxagliptin hydrochloride |
709031-78-7 |
C18H25N3O2.HCl |
 |
N-(2-(4'-cyanobiphenyl-4-yl)propyl)propane-2-sulfonaMide |
211311-95-4 |
C19H22N2O2S |
 |
CID-2011756,5-(3-chlorophenyl)-N-(4-(MorpholinoMethyl)phenyl)furan-2-carboxaMide |
638156-11-3 |
C22H21ClN2O3 |
 |
Rimegepant |
1289023-67-1 |
C28H28F2N6O3 |
 |
EVP 6124 |
550999-75-2 |
C16H17ClN2OS |
 |
Sarecycline Hydrochloride |
1035979-44-2 |
C24H30ClN3O8 |
 |
KML-29 |
1380424-42-9 |
C24H21F6NO7 |
 |
4H-1,2,4-Triazole-4-carboxaMide, 1-(2,4-dichlorophenyl) -N-(2,4-difluorophenyl)-1,5-dihydro-N-(1-Methylethyl)- 5-oxo- |
212201-70-2 |
C18H14Cl2F2N4O2 |
 |
Relugolix |
737789-87-6 |
C29H27F2N7O5S |
 |
VTX-2337 |
926927-61-9 |
C28H34N4O2 |
 |
TUG-770 |
1402601-82-4 |
C19H14FNO2 |
 |
AMD 070 hydrochloride |
880549-30-4 |
C21H28ClN5 |
 |
Azaphenonxazine dihydrochloride Monohydrate |
63302-99-8 |
C16H23Cl2N5O2 |
 |
CCT 241533 hydrochloride |
1431697-96-9 |
C23H28ClFN4O4 |
 |
CX 6258 hydrochloride hydrate |
1353858-99-7 |
C26H27Cl2N3O4 |
 |
LDE-225 Diphosphate |
1218778-77-8 |
C26H32F3N3O11P2 |
 |
LY-2795050 |
1346133-08-1 |
C23H22ClN3O2 |
 |
SodiuM Channel inhibitor 1 |
1198117-23-5 |
C24H19F4N3O3 |
 |
Tipiracil hydrochloride |
183204-72-0 |
C9H12Cl2N4O2 |
 |
EPZ011969 |
1598383-40-4 |
C35H51N5O4 |
 |
MCC950 |
210826-40-7 |
C20H24N2O5S |
![6-amino-4-(2,5-dimethoxyphenyl)-1,4-dihydro-3-(2-naphthalenyl)-pyrano[2,3-c]pyrazole-5-carbonitrile](/CAS/20180703/GIF/361185-42-4.gif) |
6-amino-4-(2,5-dimethoxyphenyl)-1,4-dihydro-3-(2-naphthalenyl)-pyrano[2,3-c]pyrazole-5-carbonitrile |
361185-42-4 |
C25H20N4O3 |
 |
WZB117 |
1223397-11-2 |
C20H13FO6 |
 |
Csn-B |
321661-62-5 |
C18H26O5 |
 |
2-(1-Piperazinyl)chinolinmaleat |
5786-68-5 |
C17H19N3O4 |
 |
Bis(4-cyanophenyl)methanol |
134521-16-7 |
C15H10N2O |
 |
CDKI-73 |
1421693-22-2 |
C15H15FN6O2S2 |
 |
3,6-Dichlorotrimellitic anhydride |
81742-10-1 |
C9H2Cl2O5 |
 |
E6446 (dihydrochloride) |
1345675-25-3 |
C27H36ClN3O3 |
 |
PDE1-IN-1 (phosphate) |
1642303-38-5 |
C29H29FN7O5P |
 |
RSV604 |
676128-63-5 |
C22H17FN4O2 |
 |
CEP-28122 |
1022958-60-6 |
C28H35ClN6O3 |
 |
HMN 176 |
173529-10-7 |
C20H18N2O4S |
 |
HM 30181A |
849675-66-7 |
C38H36N6O7 |
 |
CTEP Derivative |
802906-73-6 |
C18H13ClFN3 |
![1H-Isoindole-1,3(2H)-dione, 5-[5-[[3-(4-broMophenyl)-2-iMino-4-oxo-5-thiazolidinylidene]Methyl]-2-furanyl]-](/CAS/20150408/GIF/1420071-30-2.gif) |
1H-Isoindole-1,3(2H)-dione, 5-[5-[[3-(4-broMophenyl)-2-iMino-4-oxo-5-thiazolidinylidene]Methyl]-2-furanyl]- |
1420071-30-2 |
C22H12BrN3O4S |
 |
PF-04995274 |
1331782-27-4 |
C23H32N2O6 |
 |
AC710 |
1351522-04-7 |
C31H42N6O4 |
 |
AgoMelatine (hydrochloride) |
1176316-99-6 |
C15H18ClNO2 |
 |
Ledipasvir (acetone) |
1441674-54-9 |
C52H60F2N8O7 |
 |
SP-420 |
911714-45-9 |
C16H21NO6S |
 |
Mps1-IN-2 |
1228817-38-6 |
C26H36N6O3 |
 |
QL47 |
1469988-75-7 |
C27H21N5O2 |
 |
PF-01247324 |
875051-72-2 |
C13H10Cl3N3O |
 |
AP-III-a4 |
1177827-73-4 |
C31H43FN8O3 |
 |
PSI-7976 |
1190308-01-0 |
C22H29FN3O9P |
 |
GSK2141795 |
1047634-65-0 |
C18H16Cl2F2N4O2 |
 |
NVP-TNKS656 |
1419949-20-4 |
C27H34N4O5 |
 |
N1-(2,2,6,6-tetraMethylpiperidin-4-yl)-N2-p-tolyloxalaMide |
144217-65-2 |
C18H27N3O2 |
 |
Optovin |
348575-88-2 |
C15H13N3OS2 |
 |
Resmetirom |
920509-32-6 |
C17H12Cl2N6O4 |
 |
Dafadine-A |
1065506-69-5 |
C23H25N3O3 |
 |
GK921 |
1025015-40-0 |
C21H20N4O |
 |
LDN-27219 |
312946-37-5 |
C20H16N4O2S2 |
 |
Skp2 Inhibitor C1 |
432001-69-9 |
C18H13BrN2O4S2 |
 |
Decernotinib |
944842-54-0 |
C18H19F3N6O |
 |
JIB-04 (NSC 693627) -Z |
199596-24-2 |
C17H13ClN4 |
 |
Eluxadoline Dihydrochloride |
864825-13-8 |
C32H39Cl2N5O5 |
 |
ERDAFITINIB |
1346242-81-6 |
C25H30N6O2 |
 |
N,N'-(2,2'-(1,4-phenylene)bis(ethane-2,1-diyl))dipropane-2-sulfonaMide |
380607-77-2 |
C16H28N2O4S2 |
 |
(S)-2-phenyl-1-(thiazol-2-yl)ethanaMine hydrochloride |
135383-60-7 |
C11H13ClN2S |
 |
CPI 360 |
1802175-06-9 |
C25H31N3O4 |
 |
IKK epsilon-IN-1 |
1292310-49-6 |
C26H27N5O3 |
 |
GV-58 |
1402821-41-3 |
C18H26N6OS |
 |
Z-360 |
209219-38-5 |
C29H36N4O5 |
 |
CX-4945 (sodiuM salt) |
1309357-15-0 |
C19H13ClN3NaO2 |
 |
Exherin (trifluoroacetate) |
1135237-88-5 |
C24H35F3N8O8S2 |
 |
Pyridoclax |
1651890-44-6 |
C29H22N4 |
 |
GSK2879552 |
1401966-69-5 |
C23H28N2O2 |
 |
CAS:932749-62-7 |
932749-62-7 |
C20H16Br2O3 |
![(S)-1-((5-chloropyridin-3-yl)methyl)-8-((R)-3-methylmorpholino)-2-(trifluoromethyl)-3,4-dihydro-1H-pyrimido[1,2-a]pyrimidin-6(2H)-one](/CAS/GIF/1523406-39-4.gif) |
(S)-1-((5-chloropyridin-3-yl)methyl)-8-((R)-3-methylmorpholino)-2-(trifluoromethyl)-3,4-dihydro-1H-pyrimido[1,2-a]pyrimidin-6(2H)-one |
1523406-39-4 |
C19H21ClF3N5O2 |
 |
ML-228 |
1357171-62-0 |
C27H21N5 |
 |
4-((3,5-Dichloro-2-hydroxybenzyl)amino)-2-hydroxybenzoic acid |
1181226-02-7 |
C14H11Cl2NO4 |
 |
Wnt Agonist |
853220-52-7 |
C19H18N4O3 |
 |
N-(2-Aminophenyl)pyrazine-2-carboxamide |
926259-99-6 |
C11H10N4O |
 |
AZD 3759 |
1626387-80-1 |
C22H23ClFN5O3 |
 |
Nampt-IN-1 |
1698878-14-6 |
C20H25N3O5S |